Endocrine Reviews

Papers
(The TQCC of Endocrine Reviews is 52. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway358
Papillary Craniopharyngioma: An Integrative and Comprehensive Review301
Insulin/IGF signaling in islet biology and its therapeutic implications284
Update and Practical Recommendations for the Use of Medical Treatment of Cushing Syndrome220
Correction to: “ER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics”174
Medical Treatment of Acromegaly: Navigating the Present, Shaping the Future163
LGR4: A New Receptor Member in Endocrine and Metabolic Diseases153
DNA Damage and Repair in Thyroid Physiology and Disease147
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies125
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention119
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes118
The Molecular Biology of Midgut Neuroendocrine Neoplasms112
The Pregnancy-Associated Plasma Protein-A (PAPP-A) Story99
Effects of Maternal Vitamin D Supplementation on Childhood Health94
A Critical Assessment of Fasting to Promote Metabolic Health and Longevity93
Correction to: “The Congenital and Acquired Mechanisms Implicated in the Etiology of Central Precocious Puberty”91
Calcium-Sensing Receptor Regulation of Gastrointestinal Hormone Secretion90
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?89
Recent Advances in the Role of Autophagy in Endocrine-Dependent Tumors86
The Biology and Clinical Implications of PCSK781
Lung carcinoids (lung neuroendocrine tumors): integrated classification, molecular biology, diagnosis, and multidisciplinary management77
The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism75
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status68
Estrogen Receptor Signaling in the Immune System67
Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas66
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia65
Contemporary Biological Insights and Clinical Management of Craniopharyngioma65
Correction to: “Imaging of Pheochromocytomas and Paragangliomas”65
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance62
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction61
Steroid receptor coactivators: from basic research to translational opportunities60
Adiponectin and Adiponectin Receptors in Atherosclerosis59
Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease57
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling55
Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases54
Imaging of Pheochromocytomas and Paragangliomas53
Glycated CD59: a novel biomarker for gestational diabetes53
International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood53
Epigenetics and disease progression in neuroendocrine neoplasms52
The Cortisol Awakening Response: Regulation and Functional Significance52
0.18277287483215